2017 – Past Events

AAO 2017
Prospective, Double-Masked, Placebo-Controlled Phase 2b Trial on the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

Presented by Baruch D Kuppermann, MD, PhD
November 12, 2017
New Orleans, LA

Ophthalmology Innovation Summit @ASRS 2017
Luminate® for the Treatment of Diabetic Macular Edema

Presented by Vicken Karageozian, MD, President & Chief Medical Officer, Allegro Ophthalmics
August 10, 2017
Boston, MA

American Society of Retina Specialists (ASRS) 2017 Annual Meeting
Topline Results From Prospective, Double-Masked Phase 2b Clinical Trial Evaluating ALG-1001 Luminate® Compared to Bevacizumab in Patients With DME

Presented by David S. Boyer, MD
August 15, 2017
Boston, MA

ARVO 2017
Topline Results From Prospective, Double-masked, Placebo Controlled Phase 2b Clinical Study Evaluating Luminate® in Patients with Diabetic Macular Edema

Presented by Peter Kaiser, MD
May 8, 2017
Baltimore, MD